Finerenone Breakthrough for Non-Diabetic Kidney Patients | Science News

A breakthrough drug called finerenone is showing major promise for millions with chronic kidney disease who don’t have diabetes—offering the first real treatment option that slows kidney decline, cuts serious heart and kidney events by 23%, and reduces dangerous protein in urine, all while being safe and effective for a global population of over 800 million affected. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/34c246ae90637382